Newly developed self-expandable Niti-S MD colonic metal stent for malignant colonic obstruction
Open Access
- 27 April 2020
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Surgery
- Vol. 12 (4), 138-148
- https://doi.org/10.4240/wjgs.v12.i4.138
Abstract
BACKGROUND Colonic stents are increasingly used to treat acute malignant colonic obstructions. The WallFlex and Niti-S D type stents are the commonly used self-expandable metallic stents available in Japan since 2012. WallFlex stent has a risk of stent-related perforation because of its axial force, while the Niti-S D type stent has a risk of obstructive colitis because of its weaker radial force. Niti-S MD type stents not only overcome these limitations but also permit delivery through highly flexible-tipped smaller-caliber colonoscopes. AIM To compare the efficacy and safety of the newly developed Niti-S MD type colonic stents. METHODS This single-center retrospective observational study included 110 patients with endoscopic self-expandable metallic stents placed between November 2011 and December 2018: WallFlex (Group W, n = 37), Niti-S D type (Group N, n = 53), and Niti-S MD type (Group MD, n = 20). The primary outcome was clinical success, defined as a resolution of obstructive colonic symptoms, confirmed by clinical and radiological assessment within 48 h. The secondary outcome was technical success, defined as accurate stent placement with adequate stricture coverage on the first attempt without complications. RESULTS The technical success rate was 100% in Groups W, N, and MD, and the overall clinical success rate was 89.2% (33/37), 96.2% (51/53), and 100% (20/20) in Groups W, N, and MD, respectively. Early adverse events included pain (3/37, 8.1%), poor expansion (1/37, 2.7%), and fever (1/37, 2.6%) in Group W and perforation due to obstructive colitis (2/53, 3.8%) in Group N (likely due to poor expansion). Late adverse events (after 7 d) included stent-related perforations (4/36, 11.1%) and stent occlusion (1/36, 2.8%) in Group W and stent occlusion (2/51, 3.9%) in Group N. The stent-related perforation rate in Group W was significantly higher than that in Group N (P < 0.05). No adverse event was observed in Group MD. CONCLUSION In our early and limited experience, the newly developed Niti-S MD type colonic stent was effective and safe for treating acute malignant colonic obstruction.This publication has 18 references indexed in Scilit:
- Clinical outcomes and factors related to colonic perforations in patients receiving self-expandable metal stent insertion for malignant colorectal obstructionGastrointestinal Endoscopy, 2018
- Meta-analysis of the performance of ultrathin vs. standard colonoscopesEndoscopy, 2016
- 23rd UEG Week 2015United European Gastroenterology Journal, 2015
- A Japanese prospective multicenter study of self-expandable metal stent placement for malignant colorectal obstruction: short-term safety and efficacy within 7 days of stent procedure in 513 casesGastrointestinal Endoscopy, 2015
- Colonoscopy using a small-caliber colonoscope with passive-bending after incomplete colonoscopy due to sharp angulation or painSurgical Endoscopy, 2013
- Feasibility of a new self‐expandable metallic stent for patients with malignant colorectal obstructionDigestive Endoscopy, 2012
- Outcome and safety of self-expandable metallic stents for malignant colon obstruction: a Korean multicenter randomized prospective studySurgical Endoscopy, 2012
- Colonic Stenting as a Bridge to Surgery in Malignant Large-Bowel Obstruction: A Report from Two Large Multinational RegistriesThe American Journal of Gastroenterology, 2011
- Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancerEndoscopy, 2008
- Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patientsThe American Journal of Gastroenterology, 2002